University of California, San Francisco

Medications

Developing the first drug for a deadly bone disease

The U.S. Food and Drug Administration (FDA) recently approved palovarotene (Sohonos) as the first treatment for fibrodysplasia ossifcans progressiva (FOP), a severely disabling condition that causes abnormal bone formation ...

Medical research

Brief dialysis may be best for some kidney patients

Patients with acute kidney injury requiring outpatient dialysis after hospital discharge receive the same care as those with the more common end-stage kidney disease, according to a study led by UC San Francisco.

Gastroenterology

Small wearable device delivers big hope for kids with gut pain

Before irritable bowel syndrome (IBS) invaded her life, Taylor was a classic high-achieving teen: straight As, track, dance, student government. Then she began having nausea, constipation and shooting pains in her stomach.

Psychology & Psychiatry

Will a pill help new moms bounce back from postpartum depression?

Baby blues occurs in most new mothers, but 1 in 6 will go on to develop the more crushing symptoms of postpartum depression, which in severe and rare cases can lead to psychosis, and, in offspring, insecure attachment, difficulty ...

Oncology & Cancer

Study finds significant chemical exposures in women with cancer

In a sign that exposure to certain endocrine-disrupting chemicals may be playing a role in cancers of the breast, ovary, skin and uterus, researchers have found that people who developed those cancers have significantly higher ...

Diseases, Conditions, Syndromes

Protect yourself and loved ones with the new RSV vaccines

National medicine regulator, the Food and Drug Administration (FDA), recently approved the world's first vaccines to prevent RSV, or respiratory syncytial virus, for infants and elderly adults.

page 5 from 40